James Thrasher is an Endocrinology/Metabolic physician affiliated with University of Arkansas Medical Center. OpenAlex indexes 36 publications with 5,387 citations (h-index 20); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11400 Huron Ln
Little Rock, AR 722111847
Telephone
501-666-3666Provider last certified this registry record 12 Feb 2024.
Clinical trials
- Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®
Sponsor: Medtronic MiniMed, Inc.
- Cigarette Pack Inserts for Smoking Cessation
Sponsor: University of South Carolina
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
41 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202534 payments
- Eli Lilly and CompanyProgram year20251 payment
- Novo Nordisk IncProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
68.6%Insulin Analog22.1%Lantus Solostar20%Novolog11%Insulin Lispro10%Basaglar Kwikpen U-1008%Tresiba Flextouch U-1007%Toujeo Max Solostar6%Humalog6%Novolog Flexpen6%Humalog Kwikpen U-1005%Insulin Lispro Kwikpen U-1003%Lantus3%Fiasp Flextouch3%Fiasp3%Humalog Kwikpen U-2002%Toujeo Solostar2%Levemir Flexpen2%Tresiba Flextouch U-2002%Lyumjev1%Lyumjev Kwikpen U-1001%Admelog Solostar1%Admelog1%Insulin Aspart1%Soliqua 100-331%Part D<11 patientsGLP-1 receptor agonist19.4%Ozempic61%Mounjaro30%Trulicity8%Rybelsus1%Part D<11 patients+ 9 more classes in this area
Hormonal (systemic)
16.8%l-Thyroxine13.6%Levothyroxine Sodium84%Synthroid16%Part D≥240 patientsl-Triiodothyronine1.5%Liothyronine Sodium100%Part D≥41 patients+ 5 more classes in this area
Cardiovascular
11.7%Statin5.2%Atorvastatin Calcium60%Rosuvastatin Calcium19%Pravastatin Sodium15%Simvastatin7%Part D<11 patientsACE inhibitor1.8%Lisinopril79%Ramipril13%Lisinopril-Hydrochlorothiazide8%Part D<11 patients+ 12 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor
Diabetes Technology & Therapeutics
2025 - Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
Diabetes Technology & Therapeutics
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Monique Spillman, MD
University of Arkansas Medical Center
Erika Petersen, MD
University of Arkansas Medical Center
T. Pait, MD
University of Arkansas Medical Center
Shitiz Sriwastava, MD
University of Arkansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”